A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer

Taxane chemotherapy represents the standard of care in the second-line setting for non-small cell lung cancer (NSCLC) patients, but immunotherapy agents pose great challenges. Whether immunotherapy/chemotherapy alone or combination therapy has more benefits remains controversial. In this study, we p...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xin-Xiu, Lin, Guo-He, Wang, Bi-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666094/
https://www.ncbi.nlm.nih.gov/pubmed/36397323
http://dx.doi.org/10.1097/MD.0000000000031751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666094/
https://www.ncbi.nlm.nih.gov/pubmed/36397323
http://dx.doi.org/10.1097/MD.0000000000031751

Ejemplares similares